Zobrazeno 1 - 6
of 6
pro vyhledávání: '"mid-wavelength ultraviolet therapy (311 nm)"'
Autor:
M. B. Zhilova, V. V. Chikin
Publikováno v:
Vestnik Dermatologii i Venerologii, Vol 0, Iss 1, Pp 67-75 (2017)
Goal. To assess the therapeutic efficacy of the rotation of mid-wavelength ultraviolet therapy (311 nm) and PUVA therapy in patients with moderate to severe forms of psoriasis, and to assess the efficacy of mid-wavelength ultraviolet therapy (311 nm)
Externí odkaz:
https://doaj.org/article/2d4fa2f17dc04a17888aa5df9c0fa053
Publikováno v:
Vestnik dermatologii i venerologii. 91:67-75
Goal. To assess the therapeutic efficacy of the rotation of mid-wavelength ultraviolet therapy (311 nm) and PUVA therapy in patients with moderate to severe forms of psoriasis, and to assess the efficacy of mid-wavelength ultraviolet therapy (311 nm)
Autor:
M. B. Zhilova, V. A. Smolyannikova
Publikováno v:
Vestnik Dermatologii i Venerologii, Vol 0, Iss 1, Pp 92-98 (2017)
The authors present a clinical case study of squamous cell carcinoma in a psoriasis patient after 24 courses of phototherapy (22 courses of PUVA therapy and two courses of mid-wavelength ultraviolet therapy (311 nm)). The malignant neoplasm developed
Externí odkaz:
https://doaj.org/article/0fa2179a4fa44e5aa48a403d9be50bcb
Autor:
V. A. Smolyannikova, M. B. Zhilova
Publikováno v:
Vestnik Dermatologii i Venerologii, Vol 0, Iss 1, Pp 92-98 (2017)
The authors present a clinical case study of squamous cell carcinoma in a psoriasis patient after 24 courses of phototherapy (22 courses of PUVA therapy and two courses of mid-wavelength ultraviolet therapy (311 nm)). The malignant neoplasm developed
Publikováno v:
Vestnik dermatologii i venerologii. 86:37-42
The article presents the results of using a narrow-band mid-wavelength ultraviolet therapy (311 nm) in 79 children suffering from with atopic dermatitis. The course of treatment comprised 15 to 20 sessions of ultraviolet therapy with the maximal dose
Publikováno v:
Vestnik dermatologii i venerologii. 86:77-83
The article presents the results of tests aimed at revealing biomarkers of patients clinical response to treatment with Infliximab and phototherapy with the use of molecular and genetic technologies. The authors revealed that the predictor of evident